SpaceXs Public Debut Raises Sector Classification Question Industrials Tech or Telecommunications ONGC Shares Decline 35 on Q4 Results Amid Production Declines and Higher Writeoffs OpenAI Takes Early Lead in AI IPO Race as Confidential Filing Reports Emerge US GDP Growth Revised Lower to 16 in First Quarter 2026 Amid Profit Slowdown US Crude and Gasoline Inventories Extend Decline Tightening Supply Outlook Indian Bond Bull Market Pause Possible But Cycle Not Over Say Experts TISI Q1 2026 Earnings Deep EPS Loss Weighs on Sentiment as Stock Slips American Healthcare REIT Inc AHR Q1 2026 Earnings Strong EPS Beat Amidst Operational Improvements AIHS Q1 2026 Earnings Continued Losses Amid Challenging Market Conditions Oragenics Q2 2023 Earnings Narrowing Loss Surprises No Revenue Yet BWIN Q1 2026 Earnings EPS Misses Estimates Stock Rises on Operational Progress ICMB Q3 2025 Earnings EPS Falls Short of Estimates Stock Edges Higher Hawkins Inc HWKN Posts Solid Gains Approaching Key Resistance Amid Strong Momentum Skye Bioscience SKYE Holds Above Support After Modest Gain Akari Therapeutics AKTX Plunges 126 Amid Heightened Biotech Volatility Gulf Resources Inc GURE Slides 209 as Selling Pressure Intensifies Near Support Levels Coeptis Therapeutics Holdings Warrants COEPW Hold Steady at 001 Amid Thin Trading Teslas Musk Cites China as Top Rival in Humanoid Robot Race Amid Beijings Workforce Training Push PHUN Q1 2026 Earnings NarrowerThanExpected Loss but Revenue Uncertainty Lingers DENTSPLY SIRONa XRAY Tests Key Support as Selling Pressure Persists RZB Q1 2026 Earnings Strong Earnings Beat Bolsters Credit Profile eToro Group Ltd Q1 2026 Earnings EPS Beats Estimates by 234 Shares Rise Edison International EIX Q1 2026 Earnings EPS Beats Estimates by 712 as Utility Operations Strengthen KPTI Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Confidence VICI Q1 2026 Earnings Earnings Beat Estimate by 144 Modest Stock Reaction Aterian Inc ATER Q3 2025 Earnings Significant EPS Beat Drives Optimism PDS Biotechnology Q1 2026 Earnings EPS Beat on Narrower Loss Clinical Progress in Focus